QIAGEN Digital Insights

QIAGEN Digital Insights is a comprehensive bioinformatics software and data platform designed to advance molecular intelligence across the full spectrum of genomic research and clinical care. With 25 years of experience, over 140,000 active users, and more than 5 million patient tests analyzed, the platform serves discovery researchers, biopharma scientists, clinical laboratories, and data scientists who need trusted, expert-curated tools to translate 'omics data into actionable insights — from bench to bedside.

The portfolio spans secondary analysis, pathway analysis, clinical decision support, knowledge bases, and professional services, all unified under a single ecosystem. AI and machine learning are embedded throughout, including in Franklin by QIAGEN, a cloud-based AI-powered platform for hereditary variant interpretation, and in IPA Interpret, a feature within QIAGEN Ingenuity Pathway Analysis designed to simplify and accelerate the interpretation of complex biological data.

Secondary Analysis and NGS Workflows

• QIAGEN CLC Genomics Workbench and CLC Main Workbench provide complete NGS analysis toolkits with workflows for biomedical genomics, microbial genomics and metagenomics, and single-cell sequencing
• QIAGEN CLC Genomics Server and CLC Genomics Cloud enable enterprise-scale, cloud-enabled 'omics analysis with GUI-driven workflows and unparalleled curated content
• QCI Secondary Analysis is a cloud-based solution supporting affordable high-throughput secondary analysis for oncology and inherited disease clinical applications
• CLC Server Command Line Tools extend pipeline automation and data management capabilities for large-scale operations

Interpretation, Visualization, and Clinical Decision Support

• QIAGEN Ingenuity Pathway Analysis (IPA) enables researchers to analyze, compare, and contextualize NGS data, visualize complex 'omics datasets, and interpret experimental results within the context of biological systems
• QCI Interpret for Oncology delivers end-to-end NGS analysis, interpretation, and reporting for solid tumors, hematological malignancies, and hereditary cancers
• QCI Interpret for Hereditary Diseases provides an automated FASTQ-to-final-report solution for rare and undiagnosed diseases and carrier screening
• Franklin by QIAGEN is a cloud-based, AI-powered platform integrating the world's first open genomic community, offering flexible variant filtering, ACMG-based annotation, streamlined reporting, and integration with HGMD Professional
• QCI Precision Insights is a professional clinical interpretation service that translates molecular data specific to each patient into insights and therapeutic options

Knowledge Bases and Curated Databases

• HGMD (Human Gene Mutation Database) Professional is the largest expert-curated source of hereditary disease-causing mutations, providing direct access to over 10 million high-quality biological findings
• COSMIC (Catalogue of Somatic Mutations in Cancer) and HSMD (Human Somatic Mutation Database) Professional provide trusted, expert-curated cancer mutation data to support drug target qualification, indication expansion, and clinical trial design
• QIAGEN Biomedical Knowledge Base uses AI to find novel connections across over 640 million biomedical relationships, enabling drug repurposing and mechanism-of-action research
• QIAGEN OmicSoft Lands, including DiseaseLand, OncoLand, and ATCC Cell Line Land, offer access to over 700,000 preprocessed 'omics samples and disease studies for exploration and comparison
• ANNOVAR is available for translational research variant annotation workflows

Discovery, Research, and Data Science Solutions

• QIAGEN OmicSoft Suite provides a cloud-based NGS analysis suite for exploring and comparing data across 700,000+ disease studies with standardized, flexible workflows
• Biomarker identification and target discovery solutions augment biopharma research with 20 million findings and preprocessed 'omics samples
• Solutions are available for cancer drug discovery, mechanism of action studies, gene regulation, variant analysis, single-cell genomics, microbial and metagenomic research, and SARS-CoV-2 applications
• Good Manufacturing Practices (GMP)-compliant workflows are supported for regulated environments

Services

• Discovery Bioinformatics Services extend in-house research capabilities for genomics and 'omics projects
• Clinical Analysis and Interpretation Services provide expert support for clinical NGS testing workflows
• QCI Precision Insights delivers patient-specific molecular interpretation and therapeutic option identification as a managed service

QIAGEN Digital Insights supports deployment across cloud, server, and desktop environments, with enterprise NGS solutions available for labs of all sizes. The platform has received European IVDR certification for QCI Interpret, underscoring its compliance credentials for regulated clinical settings. Integrations span the full sample-to-insight workflow, and a Partner Program is available for organizations seeking to embed QIAGEN capabilities into their own solutions.